GNPX News and Press, Genprex Inc. From 01/04/22

Pipeline Expansion Enables Company to Target Entire Lung Cancer Market with REQORSA™ Genprex, Inc. (“Genprex” or the “Company”) (NASDAQ: GNPX ), a clinical-stage gene therapy company focused on developing life-changing therapies for...

Genprex Inc ( NASDAQ: GNPX ) is a clinical-stage gene therapy organization that concentrates on the development of life-changing gene therapies to treat people with diabetes and cancer. The company announced that it had received FTD (Fast Track Designation) from the Food and Dru...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Carnival (NYSE: CCL ) stock is heading higher on Monday despite recent concerns about the Covid-19 Omicron variant. Source: Flickr The rise in CCL stock appears to be partially related to an announcement from ...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Taiwan Semiconductor (NYSE: TSM ) stock is getting a nice boost today alongside heavy trading even without any news surrounding the company today. Source: Shutterstock The heavy trading affecting TSM stock tod...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips While vaccine stocks have attracted all the hype recently, another pharmaceutical company is in the spotlight today. Shares of Genprex (NASDAQ: GNPX ) are trading higher by over 105% on the heel of some exciting news....

InvestorPlace - Stock Market News, Stock Advice & Trading Tips We’re diving into the top penny stocks to watch today as several names in the space see major movement. Source: John Brueske/Shutterstock.com Penny stocks are a favorite among day and retail traders looking t...

Genprex (NASDAQ: GNPX) , a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes, announced that it has received fast track designation (“FTD”) from the U.S. Food and Drug Administration (“FDA”) fo...

Second FDA Fast Track Designation Further Validates the Potential of REQORSA Genprex, Inc. (“Genprex” or the “Company”) (NASDAQ: GNPX ), a clinical-stage gene therapy company focused on developing life-changing therapies for patients with ...

Genprex Has Developed a Proprietary System For Gene Delivery. The Oncoprex technology uses nanoparticles to deliver genes using intravenous administration rather than a viral vector delivered directly to the tumor site. The company's first product, Reqorsa, uses the Oncoprex system to deliver ...

GNPX is a clinical-stage biotech company developing gene therapies for the treatment of cancer and diabetes. REQORSA—the company's main pipeline molecule—is targeting the Non-Small-Cell Lung Cancer Market. GNPX's share price is currently trading at around $2 after a ...